Dane Leone analyst

Currently out of the existing stock ratings of Dane Leone, 106 are a BUY (83.46%), 20 are a HOLD (15.75%), 1 are a SELL (0.79%).

Dane Leone

Work Performance Price Targets & Ratings Chart

Analyst Dane Leone, has had 54.63% of price targets met with an average potential upside of 45.46%, reached in 270 days on average. Previously, Dane Leone worked at RAYMOND JAMES, BTIG.

Dane Leone has documented 232 price targets and ratings displayed on 39 stocks. The coverage was on Healthcare, Technology, Energy, Consumer Cyclical sectors.

Most recent stock forecast was given on RLAY, Relay Therapeutics at 19-May-2026.

Wall Street Analyst Dane Leone

Analyst best performing recommendations are on NKTX (NKARTA).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) on 12/27/2021. The price target of $17 was fulfilled within 7 days with a profit of $5.62 (49.38%), with a performance score of 70.55.

Average potential price target upside

ALLO Allogene Therapeutics BLUE Bluebird bio BPMC Blueprint Medicines Corp CYTK Cytokinetics GTHX G1 Therapeutics OCUL Ocular Therapeutix REGN Regeneron Pharmaceuticals RGNX Regenxbio SLP Simulations Plus TARS Tarsus Pharmaceuticals BRKR Bruker GLPG Galapagos NV ADR BMY Bristol-Myers Squibb Company NKTX Nkarta CMPX Compass Therapeutics XNCR Xencor SGEN Seagen AMGN Amgen AYLA Ayala Pharmaceuticals BBIO BridgeBio Pharma LIAN LianBio ADR RLAY Relay Therapeutics VYGR Voyager Therapeutics MGNX MacroGenics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Aug-2026

$6

$4.96 (476.92%)

$5

3 months 4 days ago
(17-Aug-2026)

1/10 (10%)

$3.92 (188.46%)

148

Sell Since 16-Apr-2026

7 months 5 days ago
(16-Apr-2026)

0/3 (0%)

$2.86 (55.64%)

Buy Since 04-Apr-2023

$11

$9.96 (957.69%)

$12

7 months 5 days ago
(16-Apr-2026)

0/12 (0%)

$8.63 (364.14%)

Hold Since 21-Mar-2023

$3.85

$2.81 (270.19%)

$6

7 months 7 days ago
(14-Apr-2026)

1/2 (50%)

$1.57 (68.86%)

44

Buy Since 14-May-2025

$9

$7.96 (765.38%)

$9

7 months 7 days ago
(14-Apr-2026)

1/4 (25%)

$6.72 (294.74%)

19

Show more analysts

Stocks Dane Leone covered previously. Scores are shown for active stocks only.

ADVM Adverum Biotechnologies ALR Alerislife BL Blackline BP BP PLC ADR CELG Celgene CRIS Curis JNJ Johnson & Johnson LI Li Auto RVMD Revolution Medicines SA Seabridge Gold SAGE Sage Therapeutic XLO Xilio Development

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?